Shareholders meeting

SUPRIYA LIFESCIENCE LTD. • Creating true values that bind global /Jealtlt August 22, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir (s), Sub.: Disclosure under Regulation 30 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Voting Results and Scrutinizer’s Report in respect of the business transacted by way of Postal Ballot conducted through Remote e-voting. In continuation to our letter dated July 21, 2026, and inter-alia pursuant to Regulation(s) 30 and Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Section 108 and 110 of the Companies Act, 2013 together with Companies (Management and Administration) Rules, 2014, and other applicable provisions, if any, we submit herewith the voting results of the business transacted by way of Postal Ballot in the prescribed format as Annexure A along with the consolidated report of the Scrutinizer issued in this regard as Annexure B. In this regard, we wish to inform you that as set out in the Notice of Postal Ballot, the following resolutions have been passed with the requisite majority on August 21, 2026: 1. Re-appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Key Managerial Personnel of the Company for a term of three (3) consecutive years from May 26, 2026, to May 25, 2029. (Special Resolution); The above information is also available on the website of the Company at www.supriyalifescience.com and on the website of NSDL at www.evoting.nsdl.com. We request you to kindly take the same on record and disseminate appropriately. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LTD. • Creating true values that bind global /Jealtlt Annexure A Outcome of Voting Postal Ballot in terms of Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015) Date of AGM/EGM Not Applicable Date of Postal Ballot Notice Friday, May 22, 2026 Voting Start Date & Time Thursday, July 23, 2026, at 9.00 a.m. IST Voting End Date & Time Friday, August 21, 2 026, at 5.00 p.m. IST Total number of shareholders on record date (i.e., July 17, 2026 - cut-off 79,554 date for voting purpose) No. of shareholders present in the meeting either in person or through proxy: Not applicable Promoters and Promoter Group: Public: No. of Shareholders attended the meeting through Video Conferencing: Promoters and Promoter Group: Public: Results of the Postal Ballot: Sr. Agenda Resolution Mode of Result No. Required Voting 1. Re-appointment of Mr. Balasaheb Sawant (DIN: Special Remote E- Passed with 07743507) as Whole Time Director and Key Managerial Resolution Voting Requisite Personnel of the Company for a term of three (3) majority consecutive years from May 26, 2026, to May 25, 2029. Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE Annexure - A Supriya Lifescience Limited 1 - Appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Key Managerial Personnel of the Company for a term of three (3) consecutive years from May 26, 2026, Resolution Required :Special to May 25, 2029. Whether promoter/ promoter group are interested in the agenda/resolution? No No. of % of Votes Polled No. of No. of % of Votes in Mode of Category No. of shares votes on outstanding Votes – in Votes favour on votes % of Votes against Voting held polled shares favour –Against polled on votes polled E-Voting 54967715 100.00 54967715 0 100.00 0.00 Promoter and Promoter Poll 0 0.00 0 0 0.00 0.00 54967825 Group Postal Ballot 0 0.00 0 0 0.00 0.00 Total 54967715 100.00 54967715 0 100.00 0.00 E-Voting 3167095 33.72 2989112 177983 94.38 5.62 Poll 0 0.00 0 0 0.00 0.00 Public Institutions 9393726 Postal Ballot 0 0.00 0 0 0.00 0.00 Total 3167095 33.72 2989112 177983 94.38 5.62 E-Voting 146673 0.91 143969 2704 98.16 1.84 Poll 0 0.00 0 0 0.00 0.00 Public Non Institutions 16121249 Postal Ballot 0 0.00 0 0 0.00 0.00 Total 146673 0.91 143969 2704 98.16 1.84 Total 80482800 58281483 72.41 58100796 180687 99.69 0.31 Annexure - B U DSM & Associates ~~c~:~;~SUmbargikar-Partner J. B. Nagar, Andheri (East), Mumbai -400 099. M +91 8108 555 704 / 8450 939 091 E sanam.u@dsmcs.in Einfo@dsmcs.inWwww.dsmcs.in Private & Confidential Mr. Satish Wagh Chairman & Managing Director Supriya Lifesciences Limited Registered Office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063, Maharashtra, India. Respected Sir, Report on Postal Ballot This has reference to my appointment as Scrutinizer by the Board of Directors by way of Board Resolution passed on 22nd May, 2026, in terms of Section 110 of the Companies Act, 2013 read with the Companies (Management And Administration) Rules, 2014 and the Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, for voting by Postal Ballot (only through remote e Voting) in respect of the Notice dated 22nd May, 2026, issued by Supriya Lifescience Limited (hereinafter the "Company") to all shareholders of the Company for passing of following resolution: Sr. No. Particulars Resolution Type 1. Re-appointment of Mr. Balasaheb Sawant (Din Special No.07743507) as a Whole Time Director and Key Managerial Personnel of the Company for a term of 3 (Three) consecutive years starting from 26th May, 2026 to 25th May, 2029. In this connection, I hereby submit my report as under: 1. I, CS Sanam Umbargikar, partner of M/s. -DSM & Associates, Company Secretaries, having UCN P2015MH038100, Peer Review No.2229/2022 and having our office at 103, Swaroop Centre, Behind Satellite Building, J B Nagar, Andheri (East), Mumbai - 400 099 , Maharashtra, India, is well versed with the process of e-voting and have been appointed as Scrutinizer by the Board of Directors by way of Resolution passed on 22nd May, 2026, in terms of Section 110 of the Companies Act, 2013 read with the Companies (Management And Administration) Page 1 of 5 DSM Associates Com pany Secretaries Rules, 2014 and the Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, for voting by Postal Ballot (only through remote e-Voting); 2. The Management of the Company is responsible for ensuring compliance with the requirements of the Companies Act, 2013 and rules made thereunder relating to voting through remote e-voting means on the resolution contained in the postal ballot notice sent to the equity shareholders of the Company. My responsibility as a Scrutinizer is to ensure that the remote e-voting process is conducted fairly and transparently and submit the Scrutinizer's Report of the total votes cast "In Favour" or "Against", if any, on the resolution, to the Chairman, based on the reports [Showing first 8,000 characters — download PDF for full document]